PL EN


Preferences help
enabled [disable] Abstract
Number of results
2019 | 129 | 263-267
Article title

Will Emicizumab be the support for surgeons in acquired haemophilia?

Content
Title variants
Languages of publication
EN
Abstracts
EN
Life-threatening bleeding during surgery is always a problem for the surgeon. In this paper, we have highlighted the problem of insufficient diagnosis of acquired haemophilia, as issues omitted by non-haematologists. Based on a clinical case and available literature, we presented the problem of acquired haemophilia and the latest methods for its treatment. Haemophilia is a problem for non-haematologist professionals. It is important to note that prolonged bleeding may be its symptom. There is now a new antibody emicizumab that has the potential to become an important aid in the work of surgeons.
Discipline
Year
Volume
129
Pages
263-267
Physical description
Contributors
  • Chair and Department of Thoracic Surgery, Medical University of Lublin, Lublin, Poland
  • Department of Thoracic Surgery, Holy Cross Cancer Centre in Kielce, Kielce, Poland
References
  • [1] Mingot-Castellano ME, Núñez R, Rodríguez-Martorell FJ. Acquired haemophilia: Epidemiology, clinical presentation, diagnosis and treatment. Med Clin (Barc). 2017 Apr 7; 148(7): 314-322. doi: 10.1016/j.medcli.2016.11.030
  • [2] Buczma A, Windyga J. Acquired haemophilia. Pol Arch Med Wewn. 2007 May-Jun; 117(5-6): 241-5
  • [3] Knoebl P, Marco P, Baudo F, Collins P, Huth-Kühne A, Nemes L, Pellegrini F, Tengborn L, Lévesque H; EACH2 Registry Contributors. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost. 2012 Apr; 10(4): 622-31. doi: 10.1111/j.1538-7836.2012.04654.x
  • [4] Jerzy Windyga; Nabyta hemofilia Acquired haemophilia. Journal of Transfusion Medicine 2010, 3, 4, 131-132
  • [5] Drobiecki A, Pasiarski M, Hus I, Sokołowska B, Wątek M. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report. Blood Coagul Fibrinolysis. 2013 Dec; 24(8): 874-80. doi: 10.1097/MBC.0b013e3283646635
  • [6] Afshari FT, Parikh D, Petrik V. Spontaneous Spinal Epidural Haematoma Secondary to Autoimmune Acquired Haemophilia. Case Rep Neurol. 2018 Dec 13; 10(3): 353-356. doi: 10.1159/000495028
  • [7] Kitamura T, Sato T, Ikami E, Fukushima Y, Yoda T. A Case of a Patient Who Is Diagnosed with Mild Acquired Hemophilia A after Tooth Extraction Died of Acute Subdural Hematoma due to Head Injury. Case Rep Dent. 2018 Dec 9; 2018: 7185263. doi: 10.1155/2018/7185263
  • [8] Saito M, Ogasawara R, Izumiyama K, Mori A, Kondo T, Tanaka M, Morioka M, Ieko M. Acquired hemophilia A in solid cancer: Two case reports and review of the literature. World J Clin Cases. 2018 Nov 26; 6(14) :781-785. doi: 10.12998/wjcc.v6.i14.781
  • [9] Kessler CM, Knöbl P. Acquired haemophilia: an overview for clinical practice. Eur J Haematol. 2015 Dec; 95 Suppl 81: 36-44. doi: 10.1111/ejh.12689
  • [10] Shetty S, Bhave M, Ghosh K. Acquired hemophilia a: diagnosis, aetiology, clinical spectrum and treatment options. Autoimmun Rev. 2011 Apr; 10(6): 311-6. doi: 10.1016/j.autrev.2010.11.005
  • [11] Lippi G, Favaloro EJ. Emicizumab (ACE910): Clinical background and laboratory assessment of hemophilia A. Adv Clin Chem. 2019; 88: 151-167. doi: 10.1016/bs.acc.2018.10.003
  • [12] Rodriguez-Merchan EC, Valentino LA. Emicizumab: Review of the literature and critical appraisal. Haemophilia. 2019 Jan; 25(1): 11-20. doi: 10.1111/hae.13641
  • [13] Emicizumab for haemophilia A. Aust Prescr. 2019 Feb; 42(1): 42. doi: 10.18773/austprescr.2019.010
  • [14] Weyand AC, Pipe SW. New therapies for hemophilia. Blood. 2019 Jan 31; 133(5):389-398. doi: 10.1182/blood-2018-08-872291
Document Type
short_communication
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-00325f51-9402-4d07-b96e-47d393c9625e
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.